0000899243-17-026611.txt : 20171116 0000899243-17-026611.hdr.sgml : 20171116 20171116165100 ACCESSION NUMBER: 0000899243-17-026611 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171115 FILED AS OF DATE: 20171116 DATE AS OF CHANGE: 20171116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROGERS MICHAEL W CENTRAL INDEX KEY: 0001244159 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53057 FILM NUMBER: 171208561 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS INC STREET 2: ONE MARINA PARK DRIVE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001422142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 BUSINESS PHONE: (513) 985-1920 MAIL ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP II DATE OF NAME CHANGE: 20071227 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2017-11-15 1 0001422142 Aerpio Pharmaceuticals, Inc. ARPO 0001244159 ROGERS MICHAEL W C/O AERPIO PHARMACEUTICALS, INC. 9987 CARVER ROAD, SUITE 420 CINCINNATI OH 25242 0 1 0 0 Chief Financial Officer Exhibit 24.1: Limited Power of Attorney /s/ Michael Rogers 2017-11-16 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT
                               POWER OF ATTORNEY

        Know all by these presents, that the undersigned hereby constitutes and
appoints each of Stephen Hoffman, Joseph Gardner, Danielle Lauzon, James Xu,
Amoli Pandya, and Brian Fleming, signing singly, the undersigned's true and
lawful attorney-in-fact to:

        (1)   execute for and on behalf of the undersigned, in the undersigned's
              capacity as an officer and/or director of Aerpio Pharmaceuticals,
              Inc. (the "Company"), (i) Form ID, including any attached
              documents, to effect the assignment of codes to the undersigned to
              be used in the transmission of information to the United States
              Securities and Exchange Commission using the EDGAR System,
              (ii) Forms 3, 4 and 5, (iii) Schedule 13D, (iv) Schedule 13G and
              (v) amendments of each thereof, in accordance with Section 16(a)
              of the Securities Exchange Act of 1934, as amended, and the rules
              thereunder;

        (2)   do and perform any and all acts for and on behalf of the
              undersigned which may be necessary or desirable to complete and
              execute any such Form 3, 4 or 5, Schedule 13D. Schedule 13G or any
              amendments thereto and timely file such form with the United
              States Securities and Exchange Commission and any stock exchange
              or similar authority; and

        (3)   take any other action of any type whatsoever in connection with
              the foregoing which, in the opinion of such attorney-in-fact, may
              be of benefit to, in the best interest of, or legally required by,
              the undersigned, it being understood that the documents executed
              by such attorney-in-fact on behalf of the undersigned pursuant to
              this Power of Attorney shall be in such form and shall contain
              such terms and conditions as such attorney-in-fact may approve in
              such attorney-in-fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 or Regulation 13D-G of
the Securities Exchange Act of 1934, as amended. The undersigned hereby agrees
to indemnify the attorney-in-fact and the Company from and against any demand,
damage, loss, cost or expense arising from any false or misleading information
provided by the undersigned to the attorney-in-fact.

        This Power of Attorney shall remain in full force and effect until the
              undersigned is no longer required to file Forms 3, 4 and 5 with
              respect to the undersigned's holdings of and transactions in
              securities issued by the Company, unless earlier revoked by the
              undersigned in a signed writing delivered to the foregoing
              attorneys-in-fact.  This Power of Attorney may be filed with the
              United States Securities and Exchange Commission as a confirming
              statement of the authority granted herein. This Power of Attorney
              supersedes any prior power of attorney in connection with the
              undersigned's capacity as an officer and/or director of the
              Company.  This Power of Attorney shall expire as to any individual
              attorney-in-fact if such attorney-in-fact ceases to be an
              executive officer of the Company.



       IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of November 15, 2017.


                                              /s/ Michael Rogers
                                              ----------------------------------
                                              Michael Rogers